EBR Systems Secures A$55.9 Million to Boost WiSE® CRT Commercialization

EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh ( (AU:EBR) ) has shared an update.

EBR Systems has successfully raised A$55.9 million through an institutional placement to advance the commercialization of its WiSE® CRT system, following recent FDA approval. The funds will be used to support a limited market release, expand manufacturing and sales capabilities, and prepare for broader distribution in 2026. The company also plans a Security Purchase Plan to raise an additional A$6 million, with the capital raise aimed at bolstering its market position and ensuring operational sustainability through Q4 2026.

The most recent analyst rating on (AU:EBR) stock is a Buy with a A$3.50 price target. To see the full list of analyst forecasts on EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh stock, see the AU:EBR Stock Forecast page.

More about EBR Systems, Inc. Shs Chess Depository Interests Repr 1 Sh

EBR Systems, Inc. is a medical device company based in Sunnyvale, California, specializing in the development of the world’s only wireless cardiac pacing device for heart failure. The company focuses on the commercialization of its WiSE® CRT system, which has recently received U.S. FDA approval, positioning it as a leader in innovative cardiac care solutions.

Average Trading Volume: 934,351

Find detailed analytics on EBR stock on TipRanks’ Stock Analysis page.